What FDAnews does

FDAnews is a private, for-profit information services company founded in 1972 that operates as a specialized publisher of domestic and international regulatory, legislative, and business news focused on the U.S. Food and Drug Administration and adjacent life sciences regulatory environments. The company is headquartered in Falls Church, Virginia, with an additional office presence in Cary, North Carolina (5000 Centregreen Way, Suite 200), and operates with a headcount in the 11-50 range. Its legal entity appears to be CenterWatch, suggesting FDAnews functions as a brand or division within a broader entity.

The company's core product is regulatory intelligence — news, analysis, and tracking of FDA rulemaking, enforcement, and policy developments — delivered to life sciences and medical product companies whose regulatory affairs, compliance, and quality functions depend on timely awareness of agency activity. An adjacent offering, the clinical trials listings platform, indexes more than 40,000 clinical trial listings searchable by medical condition, therapeutic area, and location, extending the company's reach into clinical research operations and patient recruitment audiences.

The business model is consistent with a subscription-based B2B information services publisher: recurring fees from professionals and organizations needing continuous regulatory monitoring and reference content. The company has been bootstrapped through its 52-year operating history with no disclosed funding rounds, and operates without disclosed product leadership, AI capabilities, mobile applications, or API integrations in the available data. The founder, David Swit, is the only identified leadership figure, indicating either a lean organizational structure or that additional management details were not captured in the source data.

Name

FDAnews

Legal name

CenterWatch

Website

https://fdanews.com

Company type

Private

Founded year

1972

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Regulatory Intelligence and News

NAICS

Broadcasting and Content Providers (516)

akta.pro primary industry

Regulatory Affairs, Labeling & Advertising/Promotion Compliance (HLAJADAI)

akta.pro secondary industry

Clinical Trials Authorization & Oversight (GCP) (HLAJADAF)

Keywords

• FDA regulatory news
• Pharmaceutical regulatory intelligence
• Medical device compliance
• Healthcare legislative updates
• Regulatory business information

Headquarters

HQ city

Falls Church

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales

Core offering

FDAnews is a provider of domestic and international regulatory, legislative, and business news aimed at organizations in FDA-regulated industries. The company delivers news, analysis, and information services to professionals in pharmaceutical, medical device, biotechnology, and related sectors. Based on its 1972 founding, the firm has operated as a long-standing information source for the FDA-regulated community.

Differentiator

Problem solved

Functional benefit

Products and services

• FDA Regulatory and Business News Service

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights2 records

Emerging players

• Advarra: Advarra provides IRB, clinical-research, and regulatory compliance services to pharma, biotech, and CROs. While more services- than content-focused, it competes with FDAnews's CenterWatch-adjacent offering by serving the same clinical-research and regulatory-affairs buyer with integrated compliance solutions.

Direct peers

• BioPharma Dive: BioPharma Dive is a B2B news outlet covering biopharma industry developments including FDA decisions, clinical trials, and policy. It targets overlapping pharmaceutical and biotech decision-makers and competes directly with FDAnews's regulated-industry news positioning.
• Citeline (Informa): Citeline, an Informa business, publishes the Pink Sheet and other long-established regulatory intelligence franchises covering FDA and global drug regulation. It directly competes with FDAnews on premium regulatory intelligence subscriptions and also operates clinical-trial databases analogous to CenterWatch.
• Regulatory Affairs Professionals Society (RAPS): RAPS is the leading professional society for regulatory affairs professionals, publishing Regulatory Focus and providing regulatory intelligence, training, and certification. It directly competes with FDAnews for the same regulatory-affairs reader audience and offers overlapping news, analysis, and educational content.
• Pharmaceutical Technology: Pharmaceutical Technology is an industry news and analysis outlet covering drug development, manufacturing, and regulation. It serves an overlapping pharma audience and competes with FDAnews for attention on regulatory and industry-business news.
• Fierce Pharma: Fierce Pharma is a widely-read B2B pharma news outlet covering FDA approvals, policy, and industry business news. It serves an overlapping audience of pharma executives and regulatory professionals and competes directly with FDAnews for attention and subscription dollars.
• Drug Information Association (DIA): DIA is a global, member-based organization that disseminates regulatory and scientific information across the drug-development lifecycle, including conferences, publications, and educational resources. It overlaps with FDAnews in providing regulatory intelligence and serves many of the same pharmaceutical and biotech professionals.

Broad incumbents

• Clarivate: Clarivate provides regulatory intelligence, clinical-trial data (Cortellis), and IP analytics to pharma and biotech. Its regulatory intelligence offerings (e.g., formerly DRG) directly overlap with FDAnews's regulated-industry intelligence value proposition as part of a much broader analytics portfolio.
• Veeva Systems: Veeva is a leading life-sciences cloud platform whose Veeva Vault RIM suite handles regulatory information management for major pharma companies. It represents a software-driven competitive threat to FDAnews's traditional regulatory intelligence content, embedding regulatory workflows inside enterprise platforms.
• Wolters Kluwer: Wolters Kluwer operates a broad portfolio of regulatory and compliance information products (including Lippincott, Medi-Span, and OneSumX for regulatory reporting). It is a much larger incumbent that competes with FDAnews across multiple pharma regulatory and compliance information segments through integrated software platforms.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FDAnews